Global Antiemetic Drugs Market 2017-2021: Strong Drug Pipeline to Boost Growth, Reports Technavio

LONDON–(BUSINESS WIRE)–#Research–According to the latest market study released by Technavio,
the global
antiemetic drugs market
is expected to grow at a CAGR of
more than 6% during the forecast period.


This research report titled ‘Global
Antiemetic Drugs Market 2017-2021
’ provides an in-depth analysis
of the market in terms of revenue and emerging market trends. This
report also includes an up to date analysis and forecasts for various
market segments and all geographical regions.

According to Sapna Jha, a lead analyst at Technavio for cardiovascular
and metabolic disorders
research, “Antiemetic drugs are
widely used for the management of various disease conditions and to
treat the side effects associated with various drugs. Various
formulatory advancements such as formulation in the form of patches,
intranasal sprays, and other newer formulatory are expected to fuel
antiemetic drugs market.”

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2
Technavio reports and get the third for free.

The market research analysis categorizes the global antiemetic drugs
market into three major application segments. They are:

  • Chemotherapy
  • Surgery
  • Gastroenteritis

Chemotherapy

Chemotherapy is a major segment for antiemetic drugs. The treatment of
nausea and vomiting caused due to debilitating side effects of
chemotherapy occupies the major market. This side effect is known as
chemotherapy-induced nausea and vomiting (CINV).

This ever-increasing chemotherapy population need to be treated with
better therapeutics to control emetic sensations, and hence, improved
quality of life. The data estimated that eight out of 10 people are
undergoing chemotherapy encounter with nausea and vomiting as side
effects during the treatment. This increasing need is substantiated with
the impressive pipeline as most of the pipeline molecules are indicated
for CINV. This will fuel the overall market in the forecast period.

Surgery

Post-operative nausea and vomiting (PONV) is a widespread problem after
surgery. The reasons for PONV include usage of anesthesia and side
effects associated with opioid analgesics. The global antiemetic surgery
treatment market is growing at a high rate compared with other segments,
owing to greater acceptance of surgical procedures in recent years due
to higher technical advancement making the procedures safe and effective.

“The data estimates that four out of five people undergoing surgery
face the issue of PONV. Such high instances of PONV among individuals
undergoing surgeries will fuel the antiemetic drugs market growth,”
says
Sapna.

Gastroenteritis

Gastroenteritis is an infectious disease causing inflammation of the
gut. It is more common in children than adults and older people. Much of
the pediatric population below five years of age have more than one
episodes of gastroenteritis in a year. The severity of disease ranges
from GI upset for 1-2 days with mild-to-severe diarrhea with emesis.
Many viruses, bacteria, and other microbes are responsible for causing
this disease. Rotavirus and norovirus are the major causative agents.

Though the cost of treatment is not so high when compared with other
diseases, the overall economic burden of the disease is high. As per the
CDC, the global burden of disease is around USD 60 billion, which is
mainly contributed by the loss of productivity and hospitalization
charges along with various other expenses.

The top vendors highlighted by Technavio’s market research analysts in
this report are:

  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer
  • Sanofi

Browse Related Reports:

Become a Technavio
Insights member
and access all three of these reports for a
fraction of their original cost. As a Technavio Insights member, you
will have immediate access to new reports as they’re published in
addition to all 6,000+ existing reports covering segments like
vaccines,
oncology,
and
urology
devices
. This subscription nets you thousands in savings,
while staying connected to Technavio’s constant transforming research
library, helping you make informed business decisions more efficiently.

About Technavio

Technavio
is a leading global technology research and advisory company. The
company develops over 2000 pieces of research every year, covering more
than 500 technologies across 80 countries. Technavio has about 300
analysts globally who specialize in customized consulting and business
research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research
techniques to ascertain the size and vendor landscape in a range of
markets. Analysts obtain information using a combination of bottom-up
and top-down approaches, besides using in-house market modeling tools
and proprietary databases. They corroborate this data with the data
obtained from various market participants and stakeholders across the
value chain, including vendors, service providers, distributors,
re-sellers, and end-users.

If you are interested in more information, please contact our media team
at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 630 333 9501
UK: +44 208 123 1770
www.technavio.com